RSSBack

16 September 2009

Technology Strategy Board announces new competitions for funding

The Technology Strategy Board is pleased to announce the opening of the September 09 competition for funding which open on 1st September 2009.

The competitions in this phase will cover:
Beacons – a £1M feasibility studies competition in the Technology Inspired area. The competition will invest in a number of feasibility studies for projects lasting up to three months attracting a grant of up to £25k (constituting up to 75% of total project costs). Projects may be collaborative or single-company. Priority areas are: Advanced Materials, Biosciences, Electronics, Photonics and Electrical Systems, High Value Manufacturing, Information & Communications Technology and nanotechnology. This competition will only be open to businesses with 50 employees or fewer.

Digital Britain – a £2M feasibility studies competition in the Challenge Led area. The competition will invest in a number of feasibility studies for projects lasting up to three months attracting a grant of up to £25k (constituting up to 75% of total project costs). Projects may be collaborative or single-company. Priority areas are: Enabling Technologies for the Internet, Applications and Services for Digital Britain, Access to Public Service Information and Cost-effective deployment and operation of digital infrastructure. This competition will be open to businesses with 250 employees or fewer.

Regenerative Medicine – a £3M feasibility studies competition in the area of Regenerative Medicine Therapeutics. The competition will invest in a number of feasibility studies for projects lasting between 3 and 6 months attracting a grant of between £50k and £100k (constituting up to 100% of total project costs). Priority areas are: Transplantation of stem cells, progenitors or tissue, stimulation of dormant repair processes, cells as delivery vehicles: genes, cytokines, small molecules and engineered cells/synthetic biology. This competition will be open to single companies or collaborations. HEIs are eligible to be partners but not leads and business must receive at least 50% of the grant.

Regenerative Medicine – a £1.5M one -stage CR&D competition in Value Systems and Business Modelling. Projects are not restricted to any specific sum (within the £1.5M) and the aim is to develop a better understanding of where and how value is created in the regenerative medicine value chain and develop business models to best capture that value. Priority areas are similar to those above: Transplantation of stem cells, progenitors or tissue, stimulation of dormant repair processes, cells as delivery vehicles: genes, cytokines, small molecules and engineered cells/synthetic biology. This competition is collaborative R&D competition where Business to Business or Science to Business applications are invited. There must be a business lead and business must receive at least 20% of the grant.

Competition documents, forms and information will be available from 1st September 2009 via the competition extranet.

Should you require any further information, please don’t hesitate to contact the competition helpline on 01355 272 155 or e-mail competitions@tsb.gov.uk


Back to top